News summarySeeking AlphaNov 13, 2026, 12:20 AM
Biostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027
Biostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027(摘要待生成)
Loading...
Biostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027(摘要待生成)